UBS Group’s Benitec Biopharma BNTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$209K Buy
17,884
+7,872
+79% +$92.1K ﹤0.01% 5454
2025
Q1
$130K Buy
10,012
+4,999
+100% +$65K ﹤0.01% 5582
2024
Q4
$63.3K Buy
5,013
+3,089
+161% +$39K ﹤0.01% 5936
2024
Q3
$17.7K Sell
1,924
-108
-5% -$992 ﹤0.01% 6232
2024
Q2
$14.2K Buy
2,032
+1,520
+297% +$10.6K ﹤0.01% 6372
2024
Q1
$2.69K Sell
512
-110
-18% -$578 ﹤0.01% 6674
2023
Q4
$2.01K Buy
622
+513
+471% +$1.66K ﹤0.01% 6964
2023
Q3
$329 Buy
109
+89
+445% +$269 ﹤0.01% 7425
2023
Q2
$82 Hold
20
﹤0.01% 7455
2023
Q1
$73 Sell
20
-55
-73% -$201 ﹤0.01% 8185
2022
Q4
$217 Sell
75
-1,612
-96% -$4.66K ﹤0.01% 9105
2022
Q3
$11K Buy
1,687
+986
+141% +$6.43K ﹤0.01% 7173
2022
Q2
$13K Buy
701
+681
+3,405% +$12.6K ﹤0.01% 6458
2022
Q1
$1K Sell
20
-163
-89% -$8.15K ﹤0.01% 8785
2021
Q4
$8K Buy
183
+121
+195% +$5.29K ﹤0.01% 7895
2021
Q3
$4K Buy
62
+44
+244% +$2.84K ﹤0.01% 7476
2021
Q2
$1K Sell
18
-67
-79% -$3.72K ﹤0.01% 8010
2021
Q1
$8K Buy
85
+67
+372% +$6.31K ﹤0.01% 7040
2020
Q4
$1K Hold
18
﹤0.01% 7164
2020
Q3
$2K Sell
18
-59
-77% -$6.56K ﹤0.01% 6747
2020
Q2
$10K Buy
+77
New +$10K ﹤0.01% 6147
2020
Q1
Sell
-42
Closed -$6K 6994
2019
Q4
$6K Buy
42
+18
+75% +$2.57K ﹤0.01% 6424
2019
Q3
$4K Buy
24
+2
+9% +$333 ﹤0.01% 6565
2019
Q2
$4K Buy
22
+16
+267% +$2.91K ﹤0.01% 6559
2019
Q1
$3K Buy
6
+3
+100% +$1.5K ﹤0.01% 6486
2018
Q4
$1K Sell
3
-5
-63% -$1.67K ﹤0.01% 6944
2018
Q3
$5K Sell
8
-7
-47% -$4.38K ﹤0.01% 6547
2018
Q2
$8K Buy
15
+1
+7% +$533 ﹤0.01% 6326
2018
Q1
$11K Sell
14
-3
-18% -$2.36K ﹤0.01% 5915
2017
Q4
$13K Hold
17
﹤0.01% 5882
2017
Q3
$10K Buy
17
+11
+183% +$6.47K ﹤0.01% 5966
2017
Q2
$2K Buy
6
+5
+500% +$1.67K ﹤0.01% 6410
2017
Q1
$1K Hold
1
﹤0.01% 6470
2016
Q4
$0 Hold
1
﹤0.01% 6748
2016
Q3
$0 Sell
1
-7
-88% ﹤0.01% 6696
2016
Q2
$2K Buy
+8
New +$2K ﹤0.01% 6498